Administrative Core
Administrative Core
批准号:
10026251
负责人:
CRAIG J. MCCLAIN
金额:
$60.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-06-10 至 2026-03-31
关键词:
Acute Liver FailureAdultAffectAlcoholic Liver DiseasesAlcoholsAmericanAreaBioinformaticsBiometryBudgetsCancer Grant Supplements (P30)Centers of Research ExcellenceChildClinical TrialsCommunitiesCommunity OutreachConflict (Psychology)CountryDevelopmentDevelopment PlansDiabetes MellitusDrug InteractionsDrug abuseEnsureEnvironmentEnvironmental HealthEnzymesEvaluationFDA approvedFacultyFundingGoalsGrantHealthHepatitis AHepatitis CHomelessnessHuman ResourcesIndividualIndustrializationItalyKentuckyLettersLiverLiver diseasesMalignant neoplasm of liverMentorsMorbidity - disease rateNational Institute of Environmental Health SciencesNational Institute on Alcohol Abuse and AlcoholismObesityOverweightPharmaceutical PreparationsPharmacology and ToxicologyPharmacotherapyPhasePhysiciansPilot ProjectsPopulationPrimary carcinoma of the liver cellsProcessPublic HealthResearchResearch InfrastructureResearch PersonnelRuralScientistServicesStructureSuperfundTeacher Professional DevelopmentTextToxicologyUnited States National Institutes of HealthUniversitiesViral hepatitiscareer developmentfaculty mentorfaculty researchformative assessmentimprovedliver injuryliver metabolismliver transplantationmicrobiomemicrobiome researchmultidisciplinarynon-alcoholicnon-alcoholic fatty liver diseasenonalcoholic steatohepatitisnovel therapeuticsopioid abusepersonalized medicineproblem drinkerprogramsranpirnaserecruitresearch and developmentsenior facultysuccesstoxicanttumor immunologyviral liver disease
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The University of Louisville Hepatobiology and Toxicology COBRE is a multidisciplinary group of
investigators focusing on the liver and liver injury, gut:liver interactions, and liver:environment/toxicant/drug
interactions, alcoholic and non-alcoholic liver injury, infectious liver diseases, liver cancer, and new liver
therapies. The purpose of the administrative core is to provide administrative, fiscal and scientific oversight for
this Phase II COBRE. This includes the overall career development and research goals of the Phase II
COBRE (including formative and summative evaluation and specific milestones); the career development plans
for junior faculty (including plans for transitioning to independence); plans for replacing key personnel (e.g.,
Project PIs, Core leaders, overall PI, pilot project PIs); oversight of the pilot projects; oversight of the
biostatistical support services; and disseminating information to the lay and scientific communities.
Liver diseases are some of the most common, rapidly increasing and poorly recognized health
problems afflicting Americans. For example, Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
is the most common cause of abnormal liver enzymes in the US, affecting about 25% of adults and about 10%
of children. Alcoholic Liver Disease is an increasing problem among those who drink. Importantly, there is no
FDA-approved therapy for either NASH or ALD. Toxicant-Induced Liver Injury is an increasingly recognized
industrial/environmental problem. Viral Liver Diseases (Hepatitis A, B, and C) remain major health problems
related to drug abuse and homelessness. Hepatocellular carcinoma and Hepatitis C are major causes for liver
related morbidity and liver transplantation in the US. Drug-Induced Liver Injury is the major reason new drugs
do not come to market and the major cause of fulminant liver failure in the US. Personalized Medicine is
increasingly recognized as an important aspect of drug therapy; and most drugs are metabolized in the liver.
Building on the success of the Phase I COBRE Administrative Core, the specific aims of this Phase II
COBRE Administrative Core are:
1. continue to provide overall administrative, fiscal and scientific oversight
2. enhance and grow the career development enterprise for project PIs
3. enhance and grow the career development/mentor development enterprise for the mentors
4. enhance and grow the research goals of the COBRE
5. continue to provide a process for replacing key personnel
6. continue to provide and enhance a summative and formative evaluation process for the COBRE,
including specific milestones
7. continue to provide a robust pilot project program to grow the overall research goals of the COBRE
8. disseminate pertinent information to the scientific and lay community
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inflammation Resolving Lipid Mediators: Novel Therapy for Alcohol AssociatedLiver Disease
-
批准号:10590047
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:CRAIG J. MCCLAIN
-
依托单位:
Administrative Supplement to Hepatobiology and Toxicology COBRE
-
批准号:10399887
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2021
-
负责人:CRAIG J. MCCLAIN
-
依托单位:
Alcoholic Hepatitis Network 3/9 University of Louisville
-
批准号:9752421
-
项目类别:
-
资助金额:$37.37万
-
财政年份:2018
-
负责人:CRAIG J. MCCLAIN
-
依托单位:
Alcoholic Hepatitis Network 3/9 University of Louisville
-
批准号:10434741
-
项目类别:
-
资助金额:$34.96万
-
财政年份:2018
-
负责人:CRAIG J. MCCLAIN
-
依托单位:
Pilot Trial UO1 DUR-928
-
批准号:10201423
-
项目类别:
-
资助金额:$6.94万
-
财政年份:2018
-
负责人:CRAIG J. MCCLAIN
-
依托单位:
Alcoholic Hepatitis Network 3/9 University of Louisville
-
批准号:10202391
-
项目类别:
-
资助金额:$36.33万
-
财政年份:2018
-
负责人:CRAIG J. MCCLAIN
-
依托单位:
Pilot Trial UO1 DUR-928
-
批准号:10441277
-
项目类别:
-
资助金额:$6.75万
-
财政年份:2018
-
负责人:CRAIG J. MCCLAIN
-
依托单位:
Pilot Trial UO1 DUR-928
-
批准号:9792232
-
项目类别:
-
资助金额:$7.28万
-
财政年份:2018
-
负责人:CRAIG J. MCCLAIN
-
依托单位:
Hepatobiology and Toxicology COBRE
-
批准号:10377890
-
项目类别:
-
资助金额:$230.96万
-
财政年份:2016
-
负责人:CRAIG J. MCCLAIN
-
依托单位:
The Role of Nutrition in the Development/Progression of Alcohol-Induced Organ Injury
-
批准号:10056411
-
项目类别:
-
资助金额:$143.7万
-
财政年份:2016
-
负责人:CRAIG J. MCCLAIN
-
依托单位:
Hepatobiology and Toxicology COBRE
-
批准号:10608165
-
项目类别:
-
资助金额:$227.43万
-
财政年份:2016
-
负责人:CRAIG J. MCCLAIN
-
依托单位:
Hepatobiology and Toxicology COBRE
-
批准号:9904694
-
项目类别:
-
资助金额:$218.07万
-
财政年份:2016
-
负责人:CRAIG J. MCCLAIN
-
依托单位:
Administrative Core
-
批准号:10608167
-
项目类别:
-
资助金额:$60.95万
-
财政年份:2016
-
负责人:CRAIG J. MCCLAIN
-
依托单位:
Freezer Supplement to Hepatobiology and Toxicology COBRE
-
批准号:10582198
-
项目类别:
-
资助金额:$6.8万
-
财政年份:2016
-
负责人:CRAIG J. MCCLAIN
-
依托单位:
The Role of Nutrition in the Development/Progression of Alcohol-Induced Organ Injury
-
批准号:8978008
-
项目类别:
-
资助金额:$153.25万
-
财政年份:2016
-
负责人:CRAIG J. MCCLAIN
-
依托单位:
Administrative Core
-
批准号:10377891
-
项目类别:
-
资助金额:$60.9万
-
财政年份:2016
-
负责人:CRAIG J. MCCLAIN
-
依托单位:
Role of Dietary Fat in Alcoholic Liver Disease
-
批准号:8978012
-
项目类别:
-
资助金额:$6.82万
-
财政年份:2016
-
负责人:CRAIG J. MCCLAIN
-
依托单位:
Dietary Fat and Alcoholic Liver Disease
-
批准号:9143207
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:CRAIG J. MCCLAIN
-
依托单位:
Administrative Core
-
批准号:10625845
-
项目类别:
-
资助金额:$43.12万
-
财政年份:2016
-
负责人:CRAIG J. MCCLAIN
-
依托单位:
The Role of Nutrition in the Development/Progression of Alcohol-Induced Organ Injury
-
批准号:9273306
-
项目类别:
-
资助金额:$153.25万
-
财政年份:2016
-
负责人:CRAIG J. MCCLAIN
-
依托单位:
海外基金